Understanding the Impact of Study Design the Role of Model-Informed Development on Dosage Selection

Maximizing on Minimal Data using Pharmacometric Modeling to Estimate the Prob. of Technical Success

Overview of CDISC ADaM Population PK Data Standard ADPPK Implementation Guide

Handling missing covariates in model-based meta-analysis (Use-case for competitive benchmarking)

Changes to Population PK/PD data and supplemental information based on FDA Guidance for PopPK

The DEM Method for Evaluating Surrogate Endpoints for Accelerated Clinical Development

Importance of Cultural Sensitivity in Transforming R&D in an International Company

Three Minute Thesis & Beyond! Short and Effective Technical Communication

Communicating the Influence Drug Development and Regulatory Decisions: A Tutorial

Science Through Story Telling with Dr. Sara ElShafie

Evaluation of covariate effects using forest plots and introduction to the coveffectsplot R package

A Gentle Introduction to Optimal Design for Pharmacometric Models

Estimands and Causal Inference in Pharmacometrics

ADA/Immunogenicity Data Handling

Review of proposed NCA ADAM standard

Update on CDISC ADaM Population PK Data Standard ADPPK

The Art and Science of Career Advancement Part 2

The Art and Science of Career Advancement Part 1

Communicating to Influence Drug Development and Regulatory Decisions: A Tutorial

Communicating in the Time of COVID

Introduction to MBMA

The Case of the Crisis of Confidence

The Case of the Pharmacometrician’s Pitiful Planning

The Case of the Extrapolated Prediction

The Case of the Not So Confirmatory Conclusion

Use of Berkeley Madonna For QSP Modeling (Dr. Yasong Lu)